Main Content start here
Main Layout
Report Description

Report Description

Egypt Pacemaker Market is expected to grow at an impressive rate during the forecast period, 2018-2028. The major factors include increasing prevalence of cardiovascular diseases, increasing government attention and supportive policies, along with rising healthcare expenditure and growing technological advancement in pacemakers.

The pacemaker is a medical device implanted to help regulate the heartbeat. This is also used to prevent heart conditions when the heartbeat is too low. A pacemaker is a medical device that is implanted in the chest to regulate the heartbeat and provide a steady rhythm. It does this by emitting electrical signals that stimulate the heart muscle to contract at a regular pace. As the number of people with cardiovascular diseases continues to increase, the demand for pacemakers has also been rising. According to a World Health Organization’s 2020 report, the coronary heart disease caused 173,871 deaths in Egypt and reached 32.40% of total deaths.

Furthermore, the two main components of the pacemaker are the leads and a pulse generator. The battery and a tiny computer are installed in the pulse generator, which is located just beneath the skin of the chest. The leads are wires that are implanted into the heart's muscle after being inserted through the veins. They sense the electrical activity of the heart as well as transmit impulses from the pulse generator to the heart muscle. The heart contracts with each impulse. Depending on the kind of pacemaker required to treat the heart condition, the pacemaker could have one to three leads.

Permanent pacemakers are majorly utilized among the pediatric population, due to the high congenital and due to the surgically acquired disturbances. Additionally, the growing demand for pacemaker implantations with patient’s ease and requiring minimally invasive procedures is a significant factor driving the Egypt pacemaker market growth.

Rising prevalence of cardiovascular diseases

Egypt is a low-to-middle income nation with a significantly increased risk of cardiovascular diseases, such as heart failure, arrhythmias, and other cardiac conditions. Cardiac conditions can cause disruptions in the heart’s electrical system, leading to an irregular heartbeat or a complete blockage of the heart's electrical signals. In Egypt Cardiovascular diseases are the leading cause for death. According to a 2017 national household STEPS Survey (World Health Organization STEPwise Approach to Surveillance), 39.2% of the Egyptian participants had approximately three risk factors that can cause cardiovascular disease. Also, the prevalence of current smoking, hypertension, diabetes mellitus, hypercholesterolemia, and obesity were notably 22.7% (43% in men versus 0.5% in women), 29.5%, 15.5%, and 19.2%.  Several heart conditions such as bradycardia, arrhythmias, ventricular fibrillation, ventricular tachycardia along with the condition of a heart failure require a pacemaker. Factors such as lifestyle disorders, excessive alcohol consumption, smoking, and obesity are contributing to the prevalence of cardiac arrhythmia and are expected to support the growth of Egypt Pacemaker Market. Rising lifestyle conditions such as obesity are common in Egypt and are contributing to the cardiovascular diseases majorly. According to the World Health Organization (WHO), Egypt is 18th in the world in terms of obesity with 32% of Egyptian adults categorized as obese. Congestive cardiac failure, hypertrophic cardiomyopathy, and fainting spells (syncope) are some conditions that could be treated with a pacemaker and is thereby one of the important factors responsible to bolster the market growth in the forecast period.

Egypt Pacemaker Market

Download Free Sample Report

Medical Tourism in Egypt

Egypt is considered among the best medical tourism destination as it offers best cost for the healthcare treatment plans. Due to its high standards for medical care, Egypt is a popular destination for medical tourists. There are 11 JCI-accredited (Joint Commission International) hospitals in the nation that offer superior care 24 hour a day. These facilities are equipped with the latest technology and staffed with highly skilled and experienced healthcare professionals. Egypt offers a wide range of cardiovascular treatment facilities for medical tourists seeking specialized medical care. These facilities include Cardiac Catheterization Laboratories, Coronary Artery Bypass Surgery, Heart Transplantation, Valve Replacement Surgery, Electrophysiology services, etc.  The travel facilities and the treatment for various health concerns for the tourists in Egypt are available fairly at lower and reasonable prices as compared to several other countries and is therefore one of the major factors contributing to the increased demand for cardiovascular treatment and pacemaker implantations in the country.

Growing Geriatric Population

According to a World Health Organization report, approximately 82% of deaths and around 67% of premature deaths are caused due to occurrence of non-communicable diseases (NCDs). With the rise in aged population around the world  the demand for pacemakers is expected to increase further. This is because the risk of developing cardiovascular diseases increases with age. Cardiovascular diseases (CAD) are particularly prevalent among the aging population in Egypt due to the high prevalence of risk factors such as hypertension, diabetes, and smoking. Among the geriatric population, factors such as smoking include a higher risk for cardiovascular diseases and thus is responsible for indirectly increases the demand for pacemakers. According to a  MoHP and WHO survey, in 2017, approximately 43.4% of males and 0.5% of females were smokers, and along with it around 24.9% of the population was physically inactive among the population. Generally, people above the age of 65 or 70 years of age have a high demand for pacemakers. This is due to the physiological changes one undergoes during the aging process in which the heart's conduction system becomes disordered. Moreover, there are conditions such as reduction in P cells and an increase in collagen in the sinoatrial node. Also in some cases, the number of conduction cells in the heart’s bundle of His and in the right & left  bundle branches also decrease, that leads to the disfunction or slow functioning of the heart and therefore  the necessity for heart treatments and having demand for pacemakers in the Egypt pacemaker market. Additionally, as the elderly population increases, there is a greater demand for healthcare services, including long-term care and specialized geriatric care. Furthermore, there may be an increased burden on the social security system, as the elderly population may require additional financial support.

Technological advancement

Growing technological advancement in pacemakers has led to an increase in demand for these devices. Technological advancement in pacemakers include  development of leadless pacemakers. These devices are smaller than traditional pacemakers and do not require leads to be implanted in the heart and reduce the risk of complications making the implantation process less invasive. Also, leadless pacemakers have a longer battery life, reducing the need for frequent replacements in the patient. Most common recent development in the pacemaker industry has been the introduction of leadless pacemakers. Unlike traditional pacemakers that require leads to be threaded through veins and attached to the heart, leadless pacemakers are self-contained devices that are implanted directly into the heart. These devices are smaller and less invasive than traditional pacemakers, and they have been shown to have fewer complications and a lower risk of infection. Additionally, the recent advancement in pacemaker technology has been the introduction of Bluetooth-enabled devices. These pacemakers can be monitored remotely by healthcare providers, allowing for more frequent and accurate tracking of patient health and reducing the need for in-person visits. This technology also allows for more efficient adjustment of pacemaker settings to meet each patient's specific needs, potentially improving outcomes and reducing the need for further interventions. These advances have made pacemakers more accessible to a broader range of patients and have led to an increase in demand for these devices including pacemakers in Egypt.

Market Segmentation

The Egypt Pacemaker Market can be segmented by type, technology, product type, application, end user, region and competitive landscape. Based on type, the market is segmented into implantable and external. Based on Product type , the market is segmented conventional, and MRI Compatible. Depending on the Application, the market is fragmented into arrythmias, congestive heart failure and others. Based on the end user the market is further divided into hospitals, cardiac care centers and ambulatory surgical centers.

Market Players

OSYPKA MEDICAL (Distributors) LivaNova, Biotronik, Abbott, MEDTRONIC EGYPT LLC, Boston Scientific, MicroPort Scientific Corporation, MEDICO S.R.L.(Distributors), etc. are some of the leading companies operating in the market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, ,company share, competitive landscape, growth factors, and trends

Segments covered

Type

Technology

Product Type

Application

End User

Regional scope

 Cairo, Alexandria, Giza, Qalyubia, Suez, Port Said,Rest of Egypt

Key companies profiled

OSYPKA MEDICAL (Distributors),LivaNova, Biotronik, Abbott, MEDTRONIC EGYPT LLC, Boston Scientific, MicroPort Scientific Corporation, MEDICO S.R.L.(Distributors)

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Egypt Pacemaker Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Egypt Pacemaker Market, By Type

o   Implantable

o   External

·         Egypt Pacemaker Market, By Technology

o   Single Chamber

o   Dual Chamber

o   Biventricular Chamber

·         Egypt Pacemaker Market, By Product Type

o   Conventional

o   MRI Compatible

·         Egypt Pacemaker Market, By Application

o   Arrythmias

o   Congestive Heart Failure

o   Others

·         Egypt Pacemaker Market, By End User

o   Hospitals

o   Cardiac Care Centers

o   Ambulatory Surgical Centers

·         Egypt Pharmaceutical Market, By Region:

o   Cairo

o   Alexandria

o   Giza

o   Qalyubia

o   Suez

o   Port Said

o   Rest of Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Egypt Pacemaker Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Egypt Pacemaker Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Egypt Pacemaker Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (Implantable, External)

5.2.2.    By Technology (Single Chamber, Dual Chamber, Biventricular Chamber)

5.2.3.    By Product Type (Conventional, MRI Compatible)

5.2.4.    By Application (Arrythmias, Congestive Heart Failure, Others)

5.2.5.    By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers)

5.2.6.    By Company (2022)

5.2.7.    By Region

5.3.  Product Market Map

6.    Egypt Implantable Pacemaker Market Outlook

6.1.  Market Size & Forecast

6.2.  Market Size & Forecast       

6.2.1.    By Value

6.3.  Market Share & Forecast

6.3.1.    By Technology  

6.3.2.    By Product Type

6.3.3.    By Application

6.3.4.    By End Users

7.    Egypt External Pacemaker Market Outlook

7.1.  Market Size & Forecast

7.2.  Market Size & Forecast       

7.2.1.    By Value

7.3.  Market Share & Forecast

7.3.1.    By Technology  

7.3.2.    By Product Type

7.3.3.    By Application

7.3.4.    By End Users  

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

9.1.  Recent Developments

9.2.  Mergers & Acquisitions

9.3.  Product Developments

10. Policy & Regulatory Landscape

11. Egypt economic profile

12. Competitive Landscape

12.1.             Business Overview

12.2.             Company Snapshot

12.3.             Products & Services

12.4.             Financials (In case of listed companies)

12.5.             Recent Developments

12.6.             SWOT Analysis

12.6.1. OSYPKA MEDICAL (Distributors)

12.6.2. LivaNova

12.6.3.  Biotronik

12.6.4.  Abbott

12.6.5.  Medtronic

12.6.6.  Boston Scientific Corporation

12.6.7.  MicroPort Scientific Corporation

12.6.8.  MEDICO S.R.L.(Distributors)

13. Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Egypt Pacemaker Market is expected to grow at an impressive rate by 2028 on account of rising prevalence of cardiovascular diseases, launching of supportive policies by government, along with rising healthcare expenditure and growing technological advancement in pacemakers.

Based on the end user, the Egypt Pacemaker Market is expected to be dominated by the hospital segment due to sufficient availability of all the facilities related to the patient care during conditions such as cardiac arrest. Also, in the hospitals there are more chances to get easy reimbursement during various surgeries.

OSYPKA MEDICAL (Distributors), LivaNova, Biotronik, Abbott, MEDTRONIC EGYPT LLC, Boston Scientific, MicroPort Scientific Corporation, MEDICO S.R.L.(Distributors), etc., are some of the leading players operating in Egypt Pacemaker Market.

High cost and stringent regulations for the manufacturing of pacemakers in the country are restraining the Egypt Pacemaker Market growth.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.